Takeda Pharmaceutical (Respiratory Business) Overview

  • Status
  • Acquired/​Merged
  • Employees
  • 200
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Takeda Pharmaceutical (Respiratory Business) General Information

Description

Developer of pharmaceutical for respiratory treatments. The company develops and distributes respiratory medicines and early pipeline products. It also supplies respiratory products, including Alvesco and Omnaris, a steroid that reduces inflammation.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • 4-1-1 Dosho-machi
  • Chuo-ku Osaka City
  • Osaka, 540-8645
  • Japan
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Takeda Pharmaceutical (Respiratory Business) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Takeda Pharmaceutical (Respiratory Business)‘s full profile, request access.

Request a free trial

Takeda Pharmaceutical (Respiratory Business) Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Takeda Pharmaceutical (Respiratory Business) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Takeda Pharmaceutical (Respiratory Business)‘s full profile, request access.

Request a free trial